AAAAAA
Results: 1-25/45
Authors:
BEASLEY CM
Citation: Cm. Beasley, SUICIDALITY WITH FLUOXETINE, CNS DRUGS, 9(6), 1998, pp. 513-514
Authors:
BEASLEY CM
SAYLER ME
KIESLER GM
POTVIN JH
SANGER TM
TOLLEFSON GD
Citation: Cm. Beasley et al., THE INFLUENCE OF PHARMACOTHERAPY ON SELF-DIRECTED AND EXTERNALLY-DIRECTED AGGRESSION IN SCHIZOPHRENIA, Schizophrenia research, 29(1-2), 1998, pp. 28-28
Authors:
REAMS SG
SANGER TM
BEASLEY CM
Citation: Sg. Reams et al., OLANZAPINE IN THE TREATMENT OF ELDERLY PATIENTS WITH SCHIZOPHRENIA AND RELATED PSYCHOTIC DISORDERS, Schizophrenia research, 29(1-2), 1998, pp. 151-152
Authors:
TAMURA RN
BEASLEY CM
DELLVA MA
GLAZER WM
MORGENSTERN H
TOLLEFSON GD
Citation: Rn. Tamura et al., WHAT IS THE DIFFERENTIAL RISK OF TARDIVE-DYSKINESIA WITH THE NOVEL ANTIPSYCHOTIC OLANZAPINE, Schizophrenia research, 29(1-2), 1998, pp. 176-176
Authors:
JONES B
CRAWFORD AMK
BEASLEY CM
TOLLEFSON GD
Citation: B. Jones et al., THE ACUTE AND LONG-TERM EFFECT OF OLANZAPINE COMPARED WITH PLACEBO AND HALOPERIDOL ON SERUM PROLACTIN CONCENTRATION, Schizophrenia research, 29(1-2), 1998, pp. 204-205
Authors:
WRIGHT P
TOLLEFSON GD
BEASLEY CM
TAMURA RN
TRAN PV
POTVIN JII
Citation: P. Wright et al., A BLINDED, CONTROLLED, LONG-TERM STUDY OF THE COMPARATIVE INCIDENCE OF TREATMENT - EMERGENT TARDIVE-DYSKINESIA WITH OLANZAPINE OR HALOPERIDOL, Schizophrenia research, 29(1-2), 1998, pp. 206-206
Authors:
HAMILTON SH
REVICKI DA
GENDUSO LA
BEASLEY CM
Citation: Sh. Hamilton et al., OLANZAPINE VERSUS PLACEBO AND HALOPERIDOL - QUALITY-OF-LIFE AND EFFICACY RESULTS OF THE NORTH-AMERICAN DOUBLE-BLIND TRIAL, Neuropsychopharmacology, 18(1), 1998, pp. 41-49
Authors:
HUDSON MF
ARMACHAIN WD
BEASLEY CM
CARLSON JR
Citation: Mf. Hudson et al., ELDER ABUSE - 2 NATIVE-AMERICAN VIEWS, The Gerontologist, 38(5), 1998, pp. 538-548
Authors:
TRAN PV
DELLVA MA
TOLLEFSON GD
WENTLEY AL
BEASLEY CM
Citation: Pv. Tran et al., ORAL OLANZAPINE VERSUS ORAL HALOPERIDOL IN THE MAINTENANCE TREATMENT OF SCHIZOPHRENIA AND RELATED PSYCHOSES, British Journal of Psychiatry, 172, 1998, pp. 499-505
Authors:
MICHELSON D
TAMURA R
SUNDELL K
BEASLEY CM
Citation: D. Michelson et al., EARLY AND LATE ADVERSE EVENT PROFILES ASSOCIATED WITH FLUOXETINE TREATMENT, Biological psychiatry, 43, 1998, pp. 301-301
Authors:
TOLLEFSON GD
SANGER TM
BEASLEY CM
TRAN PV
Citation: Gd. Tollefson et al., A DOUBLE-BLIND, CONTROLLED COMPARISON OF THE NOVEL ANTIPSYCHOTIC OLANZAPINE VERSUS HALOPERIDOL OR PLACEBO ON ANXIOUS AND DEPRESSIVE SYMPTOMS ACCOMPANYING SCHIZOPHRENIA, Biological psychiatry, 43(11), 1998, pp. 803-810
Authors:
REIMHERR FW
AMSTERDAM JD
QUITKIN FM
ROSENBAUM JF
FAVA M
ZAJECKA J
BEASLEY CM
MICHELSON D
ROBACK P
SUNDELL K
Citation: Fw. Reimherr et al., OPTIMAL LENGTH OF CONTINUATION THERAPY IN DEPRESSION - A PROSPECTIVE ASSESSMENT DURING LONG-TERM FLUOXETINE TREATMENT, The American journal of psychiatry, 155(9), 1998, pp. 1247-1253
Authors:
AMSTERDAM JD
FAWCETT J
QUITKIN FM
REIMHERR FW
ROSENBAUM JF
MICHELSON D
BEASLEY CM
Citation: Jd. Amsterdam et al., FLUOXETINE AND NORFLUOXETINE - DR. AMSTERDAM AND COLLEAGUES REPLY, The American journal of psychiatry, 155(11), 1998, pp. 1637-1637
Authors:
TOLLEFSON GD
BEASLEY CM
KUNTZ AJ
Citation: Gd. Tollefson et al., OLANZAPINE ON TRIAL - REPLY, The American journal of psychiatry, 155(1), 1998, pp. 153-155
Authors:
DELLVA MA
TRAN P
TOLLEFSON GD
WENTLEY AL
BEASLEY CM
Citation: Ma. Dellva et al., STANDARD OLANZAPINE VERSUS PLACEBO AND INEFFECTIVE DOSE OLANZAPINE INTHE MAINTENANCE TREATMENT OF SCHIZOPHRENIA, Psychiatric services, 48(12), 1997, pp. 1571-1577
Authors:
BEASLEY CM
HAMILTON SH
CRAWFORD AM
DELLVA MA
TOLLEFSON GD
TRAN PV
BLIN O
BEUZEN JN
Citation: Cm. Beasley et al., OLANZAPINE VERSUS HALOPERIDOL - ACUTE-PHASE RESULTS OF THE INTERNATIONAL DOUBLE-BLIND OLANZAPINE TRIAL, European neuropsychopharmacology, 7(2), 1997, pp. 125-137
Authors:
CRAWFORD AMK
BEASLEY CM
TOLLEFSON GD
Citation: Amk. Crawford et al., THE ACUTE AND LONG-TERM EFFECT OF OLANZAPINE COMPARED WITH PLACEBO AND HALOPERIDOL ON SERUM PROLACTIN CONCENTRATIONS, Schizophrenia research, 26(1), 1997, pp. 41-54
Authors:
TOLLEFSON GD
SANGER TM
BEASLEY CM
Citation: Gd. Tollefson et al., THE COURSE OF PRIMARY AND SECONDARY NEGATIVE SYMPTOMS IN A CONTROLLEDTRIAL WITH OLANZAPINE, Schizophrenia research, 24(1-2), 1997, pp. 192-192
Authors:
TOLLEFSON GD
LU YL
SANGER TM
BEASLEY CM
TRAN PV
Citation: Gd. Tollefson et al., OLANZAPINE IN THE TREATMENT OF SCHIZOAFFECTIVE DISORDER, Schizophrenia research, 24(1-2), 1997, pp. 192-193
Authors:
BEASLEY CM
Citation: Cm. Beasley, UNTITLED - RESPONSE, Neuropsychopharmacology, 16(1), 1997, pp. 89-90
Authors:
TRAN PV
DELLVA MA
TOLLEFSON GD
BEASLEY CM
POTVIN JH
KIESLER GM
Citation: Pv. Tran et al., EXTRAPYRAMIDAL SYMPTOMS AND TOLERABILITY OF OLANZAPINE VERSUS HALOPERIDOL IN THE ACUTE TREATMENT OF SCHIZOPHRENIA, The Journal of clinical psychiatry, 58(5), 1997, pp. 205-211
Authors:
BEASLEY CM
TOLLEFSON GD
TRAN PV
Citation: Cm. Beasley et al., EFFICACY OF OLANZAPINE - AN OVERVIEW OF PIVOTAL CLINICAL-TRIALS, The Journal of clinical psychiatry, 58, 1997, pp. 7-12
Authors:
BEASLEY CM
TOLLEFSON GD
TRAN PV
Citation: Cm. Beasley et al., SAFETY OF OLANZAPINE, The Journal of clinical psychiatry, 58, 1997, pp. 13-17
Authors:
BLUMENFIELD M
LEVY NB
SPINOWITZ B
CHARYTAN C
BEASLEY CM
DUBEY AK
SOLOMON RJ
TODD R
GOODMAN A
BERGSTROM RF
Citation: M. Blumenfield et al., FLUOXETINE IN DEPRESSED-PATIENTS ON DIALYSIS, International journal of psychiatry in medicine, 27(1), 1997, pp. 71-80
Authors:
TOLLEFSON GD
BEASLEY CM
TAMURA RN
TRAN PV
POTVIN JH
Citation: Gd. Tollefson et al., BLIND, CONTROLLED, LONG-TERM STUDY OF THE COMPARATIVE INCIDENCE OF TREATMENT-EMERGENT TARDIVE-DYSKINESIA WITH OLANZAPINE OR HALOPERIDOL, The American journal of psychiatry, 154(9), 1997, pp. 1248-1254